TY - JOUR
T1 - Correction
T2 - Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors (Proceedings of the National Academy of Sciences (2019) 116 (619-624) DOI: 10.1073/pnas.1814027116)
AU - Li, Charles
AU - Bonazzoli, Elena
AU - Bellone, Stefania
AU - Choi, Jungmin
AU - Dong, Weilai
AU - Menderes, Gulden
AU - Altwerger, Gary
AU - Han, Chanhee
AU - Manzano, Aranzazu
AU - Bianchi, Anna
AU - Pettinella, Francesca
AU - Manara, Paola
AU - Lopez, Salvatore
AU - Yadav, Ghanshyam
AU - Riccio, Francesco
AU - Zammataro, Luca
AU - Zeybek, Burak
AU - Yang-Hartwich, Yang
AU - Buza, Natalia
AU - Hui, Pei
AU - Wong, Serena
AU - Ravaggi, Antonella
AU - Bignotti, Eliana
AU - Romani, Chiara
AU - Todeschini, Paola
AU - Zanotti, Laura
AU - Zizioli, Valentina
AU - Odicino, Franco
AU - Pecorelli, Sergio
AU - Ardighieri, Laura
AU - Silasi, Dan Arin
AU - Litkouhi, Babak
AU - Ratner, Elena
AU - Azodi, Masoud
AU - Huang, Gloria S.
AU - Schwartz, Peter E.
AU - Lifton, Richard P.
AU - Schles-singer, Joseph
AU - Santin, Alessandro D.
N1 - Funding Information:
The authors note that the following statement should be added to the Acknowledgments: “This work was also supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Ovarian Cancer Research Program under Award W81XWH-15-1-0221 (to Y.Y.-H.).”
Publisher Copyright:
© 2019 National Academy of Sciences. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Correction for “Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors,” by Charles Li, Elena Bonazzoli, Stefania Bellone, Jungmin Choi, Weilai Dong, Gulden Menderes, Gary Altwerger, Chanhee Han, Aranzazu Manzano, Anna Bianchi, Francesca Pettinella, Paola Manara, Salvatore Lopez, Ghanshyam Yadav, Francesco Riccio, Luca Zammataro, Burak Zeybek, Yang Yang-Hartwich, Natalia Buza, Pei Hui, Serena Wong, Antonella Ravaggi, Eliana Bignotti, Chiara Romani, Paola Todeschini, Laura Zanotti, Valentina Zizioli, Franco Odicino, Sergio Pecorelli, Laura Ardighieri, Dan-Arin Silasi, Babak Litkouhi, Elena Ratner, Masoud Azodi, Gloria S. Huang, Peter E. Schwartz, Richard P. Lifton, Joseph Schlessinger, and Alessandro D. Santin, which was first published December 24, 2018; 10.1073/pnas.1814027116 (Proc Natl Acad Sci USA 116:619–624). The authors note that the following statement should be added to the Acknowledgments: “This work was also supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Ovarian Cancer Research Program under Award W81XWH-15-1-0221 (to Y.Y.-H.).”
AB - Correction for “Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors,” by Charles Li, Elena Bonazzoli, Stefania Bellone, Jungmin Choi, Weilai Dong, Gulden Menderes, Gary Altwerger, Chanhee Han, Aranzazu Manzano, Anna Bianchi, Francesca Pettinella, Paola Manara, Salvatore Lopez, Ghanshyam Yadav, Francesco Riccio, Luca Zammataro, Burak Zeybek, Yang Yang-Hartwich, Natalia Buza, Pei Hui, Serena Wong, Antonella Ravaggi, Eliana Bignotti, Chiara Romani, Paola Todeschini, Laura Zanotti, Valentina Zizioli, Franco Odicino, Sergio Pecorelli, Laura Ardighieri, Dan-Arin Silasi, Babak Litkouhi, Elena Ratner, Masoud Azodi, Gloria S. Huang, Peter E. Schwartz, Richard P. Lifton, Joseph Schlessinger, and Alessandro D. Santin, which was first published December 24, 2018; 10.1073/pnas.1814027116 (Proc Natl Acad Sci USA 116:619–624). The authors note that the following statement should be added to the Acknowledgments: “This work was also supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Ovarian Cancer Research Program under Award W81XWH-15-1-0221 (to Y.Y.-H.).”
UR - http://www.scopus.com/inward/record.url?scp=85063282909&partnerID=8YFLogxK
U2 - 10.1073/pnas.1902633116
DO - 10.1073/pnas.1902633116
M3 - Comment/debate
C2 - 30858325
AN - SCOPUS:85063282909
SN - 0027-8424
VL - 116
SP - 5829
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 12
ER -
